PAINS in the assay: Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS

Jayme L. Dahlin, J. Willem M Nissink, Jessica M. Strasser, Subhashree Francis, Leeann Higgins, Hui Zhou, Zhiguo Zhang, Michael A. Walters

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compounds, while understanding the chemical basis for these adverse behaviors often goes unexplored in pursuit of lead compounds. Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compounds. Herein, we characterize the chemical basis for assay interference and promiscuous enzymatic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compounds (PAINS). Protein mass spectrometry and ALARM NMR confirmed these compounds react covalently with cysteines on multiple proteins. Unfortunately, compounds containing these chemotypes have been published as screening actives in reputable journals and even touted as chemical probes or preclinical candidates. Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compounds, guide screening library design, and prevent follow-up on undesirable chemical matter.

Original languageEnglish (US)
Pages (from-to)2091-2113
Number of pages23
JournalJournal of Medicinal Chemistry
Volume58
Issue number5
DOIs
StatePublished - Mar 12 2015

Fingerprint

Histone Acetyltransferases
Triage
Drug Discovery
Sulfhydryl Compounds
Artifacts
Libraries
Cysteine
Mass Spectrometry
Proteins
Lead

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

PAINS in the assay : Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. / Dahlin, Jayme L.; Nissink, J. Willem M; Strasser, Jessica M.; Francis, Subhashree; Higgins, Leeann; Zhou, Hui; Zhang, Zhiguo; Walters, Michael A.

In: Journal of Medicinal Chemistry, Vol. 58, No. 5, 12.03.2015, p. 2091-2113.

Research output: Contribution to journalArticle

Dahlin, JL, Nissink, JWM, Strasser, JM, Francis, S, Higgins, L, Zhou, H, Zhang, Z & Walters, MA 2015, 'PAINS in the assay: Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS', Journal of Medicinal Chemistry, vol. 58, no. 5, pp. 2091-2113. https://doi.org/10.1021/jm5019093
Dahlin, Jayme L. ; Nissink, J. Willem M ; Strasser, Jessica M. ; Francis, Subhashree ; Higgins, Leeann ; Zhou, Hui ; Zhang, Zhiguo ; Walters, Michael A. / PAINS in the assay : Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS. In: Journal of Medicinal Chemistry. 2015 ; Vol. 58, No. 5. pp. 2091-2113.
@article{f716bb85cd404047911f1c0bbef16480,
title = "PAINS in the assay: Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS",
abstract = "Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compounds, while understanding the chemical basis for these adverse behaviors often goes unexplored in pursuit of lead compounds. Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compounds. Herein, we characterize the chemical basis for assay interference and promiscuous enzymatic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compounds (PAINS). Protein mass spectrometry and ALARM NMR confirmed these compounds react covalently with cysteines on multiple proteins. Unfortunately, compounds containing these chemotypes have been published as screening actives in reputable journals and even touted as chemical probes or preclinical candidates. Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compounds, guide screening library design, and prevent follow-up on undesirable chemical matter.",
author = "Dahlin, {Jayme L.} and Nissink, {J. Willem M} and Strasser, {Jessica M.} and Subhashree Francis and Leeann Higgins and Hui Zhou and Zhiguo Zhang and Walters, {Michael A.}",
year = "2015",
month = "3",
day = "12",
doi = "10.1021/jm5019093",
language = "English (US)",
volume = "58",
pages = "2091--2113",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - PAINS in the assay

T2 - Chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS

AU - Dahlin, Jayme L.

AU - Nissink, J. Willem M

AU - Strasser, Jessica M.

AU - Francis, Subhashree

AU - Higgins, Leeann

AU - Zhou, Hui

AU - Zhang, Zhiguo

AU - Walters, Michael A.

PY - 2015/3/12

Y1 - 2015/3/12

N2 - Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compounds, while understanding the chemical basis for these adverse behaviors often goes unexplored in pursuit of lead compounds. Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compounds. Herein, we characterize the chemical basis for assay interference and promiscuous enzymatic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compounds (PAINS). Protein mass spectrometry and ALARM NMR confirmed these compounds react covalently with cysteines on multiple proteins. Unfortunately, compounds containing these chemotypes have been published as screening actives in reputable journals and even touted as chemical probes or preclinical candidates. Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compounds, guide screening library design, and prevent follow-up on undesirable chemical matter.

AB - Significant resources in early drug discovery are spent unknowingly pursuing artifacts and promiscuous bioactive compounds, while understanding the chemical basis for these adverse behaviors often goes unexplored in pursuit of lead compounds. Nearly all the hits from our recent sulfhydryl-scavenging high-throughput screen (HTS) targeting the histone acetyltransferase Rtt109 were such compounds. Herein, we characterize the chemical basis for assay interference and promiscuous enzymatic inhibition for several prominent chemotypes identified by this HTS, including some pan-assay interference compounds (PAINS). Protein mass spectrometry and ALARM NMR confirmed these compounds react covalently with cysteines on multiple proteins. Unfortunately, compounds containing these chemotypes have been published as screening actives in reputable journals and even touted as chemical probes or preclinical candidates. Our detailed characterization and identification of such thiol-reactive chemotypes should accelerate triage of nuisance compounds, guide screening library design, and prevent follow-up on undesirable chemical matter.

UR - http://www.scopus.com/inward/record.url?scp=84924692170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924692170&partnerID=8YFLogxK

U2 - 10.1021/jm5019093

DO - 10.1021/jm5019093

M3 - Article

C2 - 25634295

AN - SCOPUS:84924692170

VL - 58

SP - 2091

EP - 2113

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 5

ER -